Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 31st October 2014
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Google aims to develop cancer diagnosis pill
microscope
The pill will work in conjunction will a wrist sensor.
Nano-particle pill could detect early warning signs before symptoms appear

Google's research arm, Google X, is working to develop technology that can detect cancer, heart attacks and other diseases before physical symptoms even appear.

Researchers led by molecular biologist, Dr Andrew Connor, hope to develop a pill that works in conjunction with a sensor worn on the wrist.

Nano-particles that detect disease will enter the bloodstream when the pill is swallowed while the sensor monitors the blood for early warning signs of disease.

Dr Connor told BBC News: "What we are trying to do is change medicine from reactive and transactional to proactive and preventative.

"Nanoparticles... give you the ability to explore the body at a molecular and cellular level."

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website. 

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'